Showing results (451-460 of 483) with videos related to
Sort By:
Pageof 49
Proceedings of the National Academy of Sciences of the United States of America|April 15, 2015
Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domainPragnesh Mistry, Michelle H W Laird, Ryan S Schwarz, et al.Journal of Medicinal Chemistry|February 10, 2023
Structure-Based Design of Potent Iminosugar Inhibitors of Endoplasmic Reticulum α-Glucosidase I with Anti-SARS-CoV-2 ActivitySharanbasappa S Karade, Evelyn J Franco, Ana C Rojas, et al.Plos One|October 25, 2016
Towards Development of Small Molecule Lipid II Inhibitors as Novel AntibioticsJamal Chauhan, Steven Cardinale, Lei Fang, et al.Antimicrobial Agents and Chemotherapy|September 7, 2017
Structure and Dynamics of FosA-Mediated Fosfomycin Resistance in Klebsiella pneumoniae and Escherichia coliErik H Klontz, Adam D Tomich, Sebastian Günther, et al.Plos One|August 24, 2012
A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivoAaron Petty, Eugene Myshkin, Haina Qin, et al.Proceedings of the National Academy of Sciences of the United States of America|November 13, 2020
The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filovirusesStuart Weston, Lauren Baracco, Chloe Keller, et al.Proceedings of the National Academy of Sciences of the United States of America|August 11, 2019
Second harmonic generation detection of Ras conformational changes and discovery of a small molecule binderElizabeth Donohue, Sina Khorsand, Gabriel Mercado, et al.Msystems|August 3, 2021
Species-Specific Endotoxin Stimulus Determines Toll-Like Receptor 4- and Caspase 11-Mediated Pathway Activation CharacteristicsOrna Ernst, Mohd M Khan, Benjamin L Oyler, et al.Plos One|March 17, 2022
COVID-19 Risk Stratification and Mortality Prediction in Hospitalized Indian Patients: Harnessing clinical data for public health benefitsShanmukh Alle, Akshay Kanakan, Samreen Siddiqui, et al.Oncogene|September 2, 2018
An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemiaAlok Swaroop, Jon A Oyer, Christine M Will, et al.Pageof 49